New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Raymond L. Comenzo et al.|Journal of Clinical Oncology|2012Cited by 965
Denosumab for Treatment of Hypercalcemia of MalignancyMimi I. Hu, Rajul K. Jain, Wendy Ying et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 200
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Chris Venner, Raymond L. Comenzo et al.|Haematologica|2014Cited by 129
<scp>HCV</scp>‐associated <scp>B</scp>‐cell non‐<scp>H</scp>odgkin lymphomas and new direct antiviral agentsPaul Carrier, V. Loustaud‐Ratti, Arnaud Jaccard et al.|Liver International|2015Cited by 62